| Literature DB >> 26166619 |
Navasona Krishnan1, Nicholas K Tonks2.
Abstract
Chronic stress can lead to the development of anxiety and mood disorders. Thus, novel therapies for preventing adverse effects of stress are vitally important. Recently, the protein tyrosine phosphatase PTP1B was identified as a novel regulator of stress-induced anxiety. This opens up exciting opportunities to exploit PTP1B inhibitors as anxiolytics.Entities:
Keywords: anxiolytic therapy; endocannabinoid signaling; glutamate receptor; protein tyrosine phosphatase PTP1B; stress-induced anxiety; trodusquemine/MSI-1436
Mesh:
Substances:
Year: 2015 PMID: 26166619 PMCID: PMC4530058 DOI: 10.1016/j.tins.2015.06.006
Source DB: PubMed Journal: Trends Neurosci ISSN: 0166-2236 Impact factor: 13.837